azetidine has been researched along with canavanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrigo, AP; Bates, EE; Kretz-Remy, C | 1 |
| Bromley, P; Fischbach, M | 1 |
1 review(s) available for azetidine and canavanine
| Article | Year |
|---|---|
Recombinant cell lines for stress reporter assays.
Topics: Animals; Azetidines; Canavanine; Cell Line; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Genes, Reporter; Genetic Engineering; Heat-Shock Proteins; Humans; Inorganic Chemicals; Toxicity Tests | 2001 |
1 other study(ies) available for azetidine and canavanine
| Article | Year |
|---|---|
Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
Topics: Amino Acids; Antioxidants; Azetidines; beta-Galactosidase; Canavanine; Chloramphenicol O-Acetyltransferase; Cysteine Endopeptidases; DNA-Binding Proteins; Glutathione Peroxidase; HeLa Cells; HIV Long Terminal Repeat; HIV-1; HSP70 Heat-Shock Proteins; Humans; Hydrolysis; I-kappa B Proteins; Multienzyme Complexes; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Phosphorylation; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Transcription, Genetic | 1998 |